Agenus reported $228.38M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agenus AGEN:US $ 228.38M 19.32M
Amgen AMGN:US $ 5203M 1325M
AstraZeneca AZN:LN 4817M 945M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Celldex Therapeutics CLDX:US $ 28.4M 3.11M
Chemocentryx CCXI:US $ 44.4M 3.82M
Dynavax Technologies DVAX:US $ 249.09M 69.67M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Gilead Sciences GILD:US $ 7000M 2704M
Glaxosmithkline GSK:US $ 6465M 4502M
GlaxoSmithKline GSK:LN 6465M 4502M
Immunogen IMGN:US $ 373.87M 63.79M
Intrexon XON:US $ 43.84M 3.52M
Jiangsu Hengrui Me. 600276:CH CH 13.61B 13.12B
Karyopharm Therapeutics KPTI:US $ 82.25M 71.01M
Macrogenics MGNX:US $ 21.47M 25.86M
Merck MRK:GR € 1580M 241M
Northwest Biotherapeutics NWBO:US 6.96M 8.21M
Novartis NOVN:VX SF 3625M 10227M
Novavax NVAX:US $ 1375.59M 195.37M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Rigel Pharmaceuticals RIGL:US $ 27.2M 2.52M
Sangamo Biosciences SGMO:US $ 117.7M 2.55M
Veracyte VCYT:US $ 153.45M 10.17M
YTE INCY:US $ 2435.38M 178.62M